Literature DB >> 29341487

Identification of stress-related microRNA biomarkers in type 2 diabetes mellitus: A systematic review and meta-analysis.

Ying-Zhi Liang1,2, Jia-Jiang-Hui Li1,2, Huan-Bo Xiao3, Yan He1,2, Ling Zhang1,2, Yu-Xiang Yan1,2.   

Abstract

BACKGROUND: Many studies have investigated microRNAs (miRNAs) in the detection of type 2 diabetes mellitus (T2DM). Herein, the dysregulated direction of stress-related miRNAs used as biomarkers of T2DM are summarized and analyzed.
METHODS: PubMed, EMBASE, ISI Web of Science, and three Chinese databases were searched for case-control miRNA profiling studies about T2DM. A meta-analysis under a random effect was performed. Subgroup analysis was conducted based on different tissues and species. Sensitivity analysis was conducted to confirm the robustness among studies. The effect size was pooled using ln odds ratios (ORs), 95% confidence intervals (95% CIs), and P-values.
RESULTS: The present meta-analysis included 39 case-control studies with a total of 494 miRNAs. Only 33 miRNAs were reported in three or more studies and, of these, 18 were inconsistent in their direction of dysregulation. Two significantly dysregulated miRNAs (let-7 g and miR-155) were identified in the meta-analysis. Four miRNAs (miR-142-3p, miR-155, miR-21, and miR-34c-5p) were dysregulated in patients with T2DM, whereas five miRNAs (miR-146a, miR-199a-3p, miR-200b, miR-29b and miR-30e) were dysregulated in animal models of diabetes. In addition, two dysregulated miRNAs (miR-146a and miR-21) were highly cornea specific and heart specific. In sensitivity analysis, only miR-155 was still significantly dysregulated after removing studies with small sample sizes.
CONCLUSIONS: The present meta-analysis revealed that 16 stress-related miRNAs were significantly dysregulated in T2DM. MiR-148b, miR-223, miR-130a, miR-19a, miR-26b and miR-27b were selected as potential circulating biomarkers of T2DM. In addition, miR-146a and miR-21 were identified as potential tissue biomarkers of T2DM.
© 2018 Ruijin Hospital, Shanghai Jiaotong University School of Medicine and John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  2型糖尿病; meta-analysis; meta分析; miRNA; microRNA; review; stress; type 2 diabetes mellitus; 应激; 综述

Mesh:

Substances:

Year:  2018        PMID: 29341487     DOI: 10.1111/1753-0407.12643

Source DB:  PubMed          Journal:  J Diabetes        ISSN: 1753-0407            Impact factor:   4.006


  24 in total

Review 1.  Extracellular miRNAs: From Biomarkers to Mediators of Physiology and Disease.

Authors:  Marcelo A Mori; Raissa G Ludwig; Ruben Garcia-Martin; Bruna B Brandão; C Ronald Kahn
Journal:  Cell Metab       Date:  2019-08-22       Impact factor: 27.287

2.  MicroRNA-375 repression of Kruppel-like factor 5 improves angiogenesis in diabetic critical limb ischemia.

Authors:  Michael G McCoy; Anurag Jamaiyar; Grasiele Sausen; Henry S Cheng; Daniel Pérez-Cremades; Rulin Zhuang; Jingshu Chen; Philip P Goodney; Mark A Creager; Marc S Sabatine; Marc P Bonaca; Mark W Feinberg
Journal:  Angiogenesis       Date:  2022-09-08       Impact factor: 10.658

Review 3.  Insight into the Role of the PI3K/Akt Pathway in Ischemic Injury and Post-Infarct Left Ventricular Remodeling in Normal and Diabetic Heart.

Authors:  Bartosz Walkowski; Marcin Kleibert; Miłosz Majka; Małgorzata Wojciechowska
Journal:  Cells       Date:  2022-05-05       Impact factor: 7.666

Review 4.  microRNA signatures associated with fetal growth restriction: a systematic review.

Authors:  P Kochhar; M Vukku; R Rajashekhar; A Mukhopadhyay
Journal:  Eur J Clin Nutr       Date:  2021-11-05       Impact factor: 4.884

Review 5.  Therapeutic Potential of miRNAs for Type 2 Diabetes Mellitus: An Overview.

Authors:  Pads Palihaderu; Bilm Mendis; Jmkjk Premarathne; Wkrr Dias; Swee Keong Yeap; Wan Yong Ho; A S Dissanayake; I H Rajapakse; P Karunanayake; U Senarath; D A Satharasinghe
Journal:  Epigenet Insights       Date:  2022-10-15

6.  Plasma levels of miR-29b and miR-200b in type 2 diabetic retinopathy.

Authors:  Maria Enoia Dantas da Costa E Silva; Evelise Regina Polina; Daisy Crispim; Renan Cesar Sbruzzi; Daniel Lavinsky; Felipe Mallmann; Nidiane Carla Martinelli; Luis Henrique Canani; Katia Gonçalves Dos Santos
Journal:  J Cell Mol Med       Date:  2018-11-23       Impact factor: 5.310

7.  Serum microRNA-33 levels in pre-diabetic and diabetic patients.

Authors:  Beydolah Shahouzehi; Mostafa Eghbalian; Hossein Fallah; Soheil Aminizadeh; Yaser Masoumi-Ardakani
Journal:  Mol Biol Rep       Date:  2021-06-19       Impact factor: 2.316

8.  MiR-142-3p ameliorates high glucose-induced renal tubular epithelial cell injury by targeting BOD1.

Authors:  Ningmin Zhao; Qing Luo; Ruijuan Lin; Qiaoyan Li; Peizhi Ma
Journal:  Clin Exp Nephrol       Date:  2021-06-18       Impact factor: 2.617

Review 9.  Crosstalk Between the Unfolded Protein Response, MicroRNAs, and Insulin Signaling Pathways: In Search of Biomarkers for the Diagnosis and Treatment of Type 2 Diabetes.

Authors:  Chinar Berry; Megha Lal; B K Binukumar
Journal:  Front Endocrinol (Lausanne)       Date:  2018-05-02       Impact factor: 5.555

10.  A surrogate of Roux-en-Y gastric bypass (the enterogastro anastomosis surgery) regulates multiple beta-cell pathways during resolution of diabetes in ob/ob mice.

Authors:  Chloé Amouyal; Julien Castel; Claudiane Guay; Amélie Lacombe; Jessica Denom; Stéphanie Migrenne-Li; Christine Rouault; Florian Marquet; Eleni Georgiadou; Theodoros Stylianides; Serge Luquet; Hervé Le Stunff; Raphael Scharfmann; Karine Clément; Guy A Rutter; Olivier Taboureau; Christophe Magnan; Romano Regazzi; Fabrizio Andreelli
Journal:  EBioMedicine       Date:  2020-07-30       Impact factor: 8.143

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.